GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Days Payable

Kimia Biosciences (BOM:530313) Days Payable : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Days Payable?

Kimia Biosciences's average Accounts Payable for the six months ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Cost of Goods Sold for the six months ended in . 20 was ₹0.00 Mil.

The historical rank and industry rank for Kimia Biosciences's Days Payable or its related term are showing as below:

BOM:530313's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 89.33
* Ranked among companies with meaningful Days Payable only.

Kimia Biosciences's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00).


Kimia Biosciences Days Payable Historical Data

The historical data trend for Kimia Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Days Payable Chart

Kimia Biosciences Annual Data
Trend
Days Payable

Kimia Biosciences Semi-Annual Data
Days Payable

Competitive Comparison of Kimia Biosciences's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Days Payable falls into.



Kimia Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Kimia Biosciences's Days Payable for the fiscal year that ended in . 20 is calculated as

Days Payable (A: . 20 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Kimia Biosciences's Days Payable for the quarter that ended in . 20 is calculated as:

Days Payable (Q: . 20 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: . 20 ) + Accounts Payable (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 2
=0 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kimia Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines